Idxg stock.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +909.17% increase from the last price of 1.09. Chart unavailable.

Idxg stock. Things To Know About Idxg stock.

Gerald Belle, Director at Interpace Diagnostics Group (IDXG), has a 16.67% success rate when buying and selling stocks. ... Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. ETF Center ...Find the latest ANI Pharmaceuticals, Inc. (ANIP) stock quote, history, news and other vital information to help you with your stock trading and investing.IDXG Earnings Date and Information. Interpace Biosciences last issued its earnings results on November 8th, 2023. The business services provider reported ($0.12) EPS for the quarter. The business had revenue of $9.08 million for the quarter.NASDAQ Health Care/Life Sciences Compare to Open 0.90 Prior Close 1.00 (11/07/23) 1 Day IDXG -5.00% DJIA 0.17% Russell 2K -0.28% Health Care/Life Sciences 1.90% …

١٨ جمادى الأولى ١٤٤١ هـ ... Parsippany, NJ, January 13, 2020 -- Interpace Biosciences, Inc. (Nasdaq: IDXG) ... The new Series B Preferred Stock investment will be convertible ...

Parsippany, NJ, Nov. 25, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (NASDAQ: IDXG) today announced that Jack Stover, President & Chief Executive Officer, will retire effective December 31, 2020.He will be replaced as President and Chief Executive Officer by Thomas Burnell, PhD., effective December 1, 2020.

Take a look at our analysis of IDXG's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.; When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team.U.S. Stock Market Overview Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks. New. Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator. New. Dividend Stocks Dividend News Dividend Calendar.Interpace Biosciences Inc (IDXG) Stock Price & News - Google Finance Home IDXG • OTCMKTS Interpace Biosciences Inc Follow Share $0.90 Oct 18, 2:52:04 PM GMT-4 · …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

David Kerr Senior VP Business Development at Interpace Diagnostics Group, is currently unranked, see this insider's latest transactions.

Interpace Biosciences Inc. (IDXG) Message Board - Company Name: Interpace Biosciences Inc., Stock Symbol: IDXG, Industry: Medical - Healthcare - Total Posts: 2811 - Last Post: 07/11/2023 09:52:18 AM - company/specific stock board

INTERPACE BIOSCIENCES INC. quote : historical data and live quotes, charts, news, analyses, trading signals, calendar, informations and community toolsSuneet Singal announces successful $350M real estate acquisition by FTE Networks Inc. & $100M Stock Distribution to the common shareholders of First Capital Real Estate Trust Inc. November 11, 2019 | www.msn.com. BRIEF-FTE Networks Reports Extension Of Indebtedness And Continuing Negotiations For Possible Business Combination.Interpace Biosciences, Inc. (IDXG) stock forecast and price target. Find the latest Interpace Biosciences, Inc. IDXG analyst stock forecast, price target, and recommendation trends with in-depth ...IDXG Stock Return DVA Stock Return ... We favor stocks that offer meaningfully greater expected return in the next 3 years; These returns are calculated based on our revenue forecast and Price to Sales Ratio (P/S) scenarios considered; Similar Price To Sales Ratio (P/S) scenarios are considered for both stocks and each scenario is weighted ...View the latest Interpace Biosciences Inc. (IDXG) stock price, news, historical charts, analyst ratings and financial information from WSJ. Interpace Biosciences Inc’s trailing 12-month revenue is $37.4 million with a -40.8% profit margin. Year-over-year quarterly sales growth most recently was -28.1%. There are not analysts providing consensus earnings estimates for the current fiscal year. Interpace Biosciences Inc does not currently pay a dividend.In-Network Access for More Than 3 Million Members. Parsippany, NJ, March 10, 2020 (GLOBE NEWSWIRE) -- Interpace Diagnostics, a subsidiary of Interpace Biosciences (NASDAQ: IDXG) announced today that it has entered into a contract with Blue Cross Blue Shield of Massachusetts with over 3 million members in Massachusetts and across New …

Interpace Biosciences, Inc. (IDXG.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Interpace Biosciences, Inc. | OTC …Interpace Diagnostics to Present New Data in Six Posters Related to PancraGEN™ at Upcoming Annual DDW International Meeting on May 6-9, 2017 PR NewswireSuite 310. 2001 Route 46. Parsippany, New Jersey 07054. Phone 1 855 776-6419. Industry Medical Equipment/Supplies. Sector Health Care/Life Sciences. Fiscal Year-end 12/2023. Revenue $31.84M.Discover historical prices for IDXG stock on Yahoo Finance. View daily, weekly or monthly formats back to when Interpace Diagnostics Group, Inc. stock was …Interpace Diagnostics Stock Earnings. The value each IDXG share was expected to gain vs. the value that each IDXG share actually gained. Interpace Diagnostics ( IDXG) reported Q3 2022 earnings per share (EPS) of -$3.35, missing estimates of -$0.25 by 1,239.76%. In the same quarter last year, Interpace Diagnostics 's earnings per share (EPS) was ...

Find the latest Interpace Biosciences, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Jan 7, 2022 · Suneet Singal announces successful $350M real estate acquisition by FTE Networks Inc. & $100M Stock Distribution to the common shareholders of First Capital Real Estate Trust Inc. November 11, 2019 | www.msn.com. BRIEF-FTE Networks Reports Extension Of Indebtedness And Continuing Negotiations For Possible Business Combination.

About the Interpace Biosciences, Inc. stock forecast. As of 2023 December 03, Sunday current price of IDXG stock is 1.030$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Interpace Biosciences stock price has been showing a declining tendency so we believe that similar market segments were …Interpace Biosciences Inc (OTC:IDXG) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more ...IDXG - Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results. home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. November, 13 2019 04:40 PM | GlobeNewswire | More on IDXG …Interpace Biosciences Inc (IDXG) Stock Price & News - Google Finance Home IDXG • OTCMKTS Interpace Biosciences Inc Follow Share $0.90 Oct 18, 2:52:04 PM GMT-4 · …Interpace Biosciences, Inc. company earnings calendar and analyst expectations - Upcoming and past events | OTC Markets: IDXG | OTC MarketsThe Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ... Suneet Singal announces successful $350M real estate acquisition by FTE Networks Inc. & $100M Stock Distribution to the common shareholders of First Capital Real Estate Trust Inc. November 11, 2019 | www.msn.com. BRIEF-FTE Networks Reports Extension Of Indebtedness And Continuing Negotiations For Possible Business …

IDXG Interpace Biosciences Inc Amended Statement of Beneficial Ownership (sc 13d/a) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities ...

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Interpace Biosciences Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The median estimate represents a +909.17% increase from the last price of 1.09. Chart unavailable.

Stock Symbol NASDAQ:IDXG. Funding Rounds 1. Total Funding Amount $3.9M. Total Funding Amount . Unlock for free . Funding. Interpace Biosciences has raised a total of . $3.9M. in funding over 1 round. This was a Post-IPO Equity round raised on Feb 8, 2017. Interpace Biosciences is registered under the ticker NASDAQ:IDXG .Get the latest Interpace Biosciences, Inc. (IDXG) stock news and headlines to help you in your trading and investing decisions.The estimated Net Worth of Thomas W. Burnell is at least $437 Mille dollars as of 21 May 2021. Dr Burnell owns over 10,855 units of Interpace Biosciences Inc stock worth over $11,723 and over the last 2 years he sold IDXG stock worth over $0. In addition, he makes $425,004 as Pres e CEO & Director at Interpace Biosciences Inc.Find the latest Interpace Biosciences, Inc. (IDXG) stock quote, history, news and other vital information to help you with your stock trading and investing.Interpace Biosciences Inc’s trailing 12-month revenue is $37.4 million with a -40.8% profit margin. Year-over-year quarterly sales growth most recently was -28.1%. There are not analysts providing consensus earnings estimates for the current fiscal year. Interpace Biosciences Inc does not currently pay a dividend.home / stock / idxg / idxg news. RSS . IDXG IDXG Quote IDXG Short IDXG News IDXG Articles IDXG Message Board. November, 08 2023 03:29 PM | GlobeNewswire | More on IDXG.Gregory Richard - IDXG / Interpace Diagnostics Group, Inc. - Insider Trade Report ... (Stocks) Options Flow - Last 7 Days (ETF) Gamma Squeeze; Gamma Pockets; Put/Call Ratio - Top Bullish; Put Call Ratio - Top Bearish; SEC FILINGS SEC Forms Latest S1 (IPO) Filings Latest 13D/G Filings Latest 13F Filings. SCREENERDiscover historical prices for IDXG stock on Yahoo Finance. View daily, weekly or monthly format back to when Interpace Biosciences, Inc. stock was issued.The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...Jul 1, 2021 · A solid price increase over a period of 12 weeks reflects investors' continued willingness to pay more for the potential upside in a stock. IDXG is quite a good fit in this regard, gaining 42.5% ... Interpace Biosciences Inc (OTCQX US:IDXG) Interpace Biosciences Inc. 1.05. Delayed Data. As of Nov 21. -0.09 / -7.89%. Today’s Change. 0.51. Today ||| 52-Week Range.

IDXG Stock Return DVA Stock Return ... We favor stocks that offer meaningfully greater expected return in the next 3 years; These returns are calculated based on our revenue forecast and Price to Sales Ratio (P/S) scenarios considered; Similar Price To Sales Ratio (P/S) scenarios are considered for both stocks and each scenario is weighted ...PARSIPPANY, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) today announced financial results for the third quarter ended ...Dr D IDXG stock SEC Form 4 insiders trading. Dr has made over 1 trades of the Interpace Biosciences Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 10,855 units of IDXG stock worth $94,221 on 21 May 2021.10,855 units of IDXG stock worth $94,221 on 21 May 2021.Top Analyst Stocks Top Smart Score Stocks Top Insiders Stocks. Popular. Stock Screener Top Online Growth Stocks Trending Stocks Penny Stock Screener. Dividend Investing. Dividend Calculator Dividend Yield Calculator Dividend Stocks Dividend News Dividend Calendar. ETFs. ETF Center Compare ETFs SPY ETF.Instagram:https://instagram. pot stocks newsis meet beagle securevinfast stock price chartbiotech catalyst calendar Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations PR Newswire PARSIPPANY, N.J., best mortgage lenders in new jerseyonline budgeting classes It operates under one segment which is the business of developing and selling diagnostic clinical services. In depth view into IDXG (Interpace Biosciences) stock including the latest price, news, dividend history, earnings information and financials.PARSIPPANY NJ, June 20, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that its ThyGeNEXT™ and ThyraMIR ® tests for thyroid cancer are now covered by Independence Blue Cross (Independence), providing plan benefits coverage for its members who meet established medical criteria for the … cigna corp stock Stock Symbol NASDAQ:IDXG. Funding Rounds 1. Total Funding Amount $3.9M. Total Funding Amount . Unlock for free . Funding. Interpace Biosciences has raised a total of . $3.9M. in funding over 1 round. This was a Post-IPO Equity round raised on Feb 8, 2017. Interpace Biosciences is registered under the ticker NASDAQ:IDXG .James Early IDXG stock SEC Form 4 insiders trading. James has made over 1 trades of the Interpace Biosciences Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently James exercised 5,000 units of IDXG stock worth $4,750 on 29 July 2020.5,000 units of IDXG stock worth $4,750 on 29 July 2020.Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.